Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|February 1, 1995
RNA enzymes as tools for gene ablationW James, A al-Shamkhani
The British Journal of Surgery|July 19, 2019
Immuno-oncology for surgeonsS L Lee, A Al-Shamkhani, A Mirnezami
European Journal of Immunology|October 10, 2001
Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154L E Haswell, M J Glennie, A Al-Shamkhani
European Journal of Immunology|August 1, 1996
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligandA al-Shamkhani, M L Birkeland, M Puklavec, et al.
Selective Cancer Therapeutics|January 1, 1991
Synthetic polymers conjugated to monoclonal antibodies: vehicles for tumour-targeted drug deliveryL W Seymour, P A Flanagan, A al-Shamkhani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID miceV Malmström, D Shipton, B Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and functionS M Tan, R H Hyland, A Al-Shamkhani, et al.
Pageof 2